Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03398148
Brief Title: A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Ulcerative Colitis Who Have Failed Prior Biologic Therapy

First Submitted : January 8, 2018
First Submitted that Met QC Criteria : January 8, 2018
First Posted : January 12, 2018

Last Update Submitted that Met QC Criteria : October 18, 2019
Last Update Posted : October 22, 2019 (Estimate)